In prostate cancer, as a key metabolite of Phellodendron amurense bark extract, palmatine synergistically inhibits the rpS6/NF-κB/FLIP signaling axis along with other bioactive metabolites, effectively reducing tumor invasiveness (Hambright et al., 2015). Here, NFKB1 is linked to prostate cancer.